Despite the many links between myeloperoxidase (MPO), oxidant stress, and the evolution of atherosclerotic coronary artery disease (CAD), many critical questions remain. For example, a direct demonstration of a causal role for MPO in atherosclerotic CAD in humans is not yet established. Moreover, mechanisms for regulating MPO in vivo remain unknown. The present application represents a logical progression of our studies and a direct effort to address these important questions. It is predicated upon the hypothesis that MPO and its newly discovered interactions with the HDL associated protein paraoxonase 1 (PON1) are genetically and mechanistically linked to oxidative stress and the development of cardiovascular disease. It integrates studies on basic mechanisms of action, interaction and molecular structure along with a search for specific reaction products to reveal whether relevant pathways operate in human disease, and in animal models of inflammation and cardiovascular disorders. The overall goals of this proposal are to: (i) define at both the structural and functional level MPO interactions with the HDL associated protein P0N1 and the reciprocal effects of MPO and PON1 on the regulation of each other's catalytic activity;and (ii) use a combination of genetic and biochemical approaches to explore the role of MPO, PON1 and specific oxidation pathways in development of CVD. We will achieve this through the following specific aims:
Aim 1) We will testing the hypothesis that MPO, HDL and PON1 form a functional ternary complex that plays a role in the reciprocal regulation of MPO and PON1 activities in vivo.
Aim 2) We will test the hypothesis that genetic and biochemical determinants of MPO and PON1 are linked to oxidant stress and coronary atherosclerotic plaque development, progression and adverse cardiac events in vivo. Collectively, the proposed studies represent an integrated, multidisciplinary and systematic approach designed to elaborate mechanisms linking MPO, oxidant stress and atherogenesis. The proposed studies will provide new insights into clinically important questions investigating a potential causal role of MPO and oxidant stress in atherogenesis. Successful completion of these studies will help discover key structural and functional relationships linking MPO with risks for development of prevalent cardiovascular disease, plaque progression and major adverse cardiovascular events.
The proposed studies will also provide new insights into how a key protein found in white blood cells, myeloperoxidase (MPO), contributes to oxidative stress and inflammatory injury within the coronary vessel wall. These studies will also help identify new diagnostic tests for heart disease risk prediction, and potential therapeutic targets for treatment and prevention of heart disease.
|Szpak, Dorota; Izem, Lahoucine; Verbovetskiy, Dmitriy et al. (2018) ?M?2 Is Antiatherogenic in Female but Not Male Mice. J Immunol 200:2426-2438|
|Sarvestani, Samaneh K; Signs, Steven A; Lefebvre, Veronique et al. (2018) Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids. Oncotarget 9:28717-28730|
|Li, Xinmin S; Wang, Zeneng; Cajka, Tomas et al. (2018) Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI Insight 3:|
|Arif, Abul; Yao, Peng; Terenzi, Fulvia et al. (2018) The GAIT translational control system. Wiley Interdiscip Rev RNA 9:|
|Eswarappa, Sandeep M; Potdar, Alka A; Sahoo, Sarthak et al. (2018) Metabolic origin of the fused aminoacyl-tRNA synthetase, glutamyl-prolyl-tRNA synthetase. J Biol Chem 293:19148-19156|
|Halawani, Dalia; Gogonea, Valentin; DiDonato, Joseph A et al. (2018) Structural control of caspase-generated glutamyl-tRNA synthetase by appended noncatalytic WHEP domains. J Biol Chem 293:8843-8860|
|Brown, J Mark; Hazen, Stanley L (2018) Microbial modulation of cardiovascular disease. Nat Rev Microbiol 16:171-181|
|Brown, J Mark; Hazen, Stanley L (2017) Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery. J Biol Chem 292:8560-8568|
|Senthong, Vichai; Wu, Yuping; Hazen, Stanley L et al. (2017) Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index. Am Heart J 184:17-25|
|Mollenhauer, Martin; Friedrichs, Kai; Lange, Max et al. (2017) Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling. Circ Res 121:56-70|
Showing the most recent 10 out of 271 publications